Skip to main content
$22.28 $0.31 (1.4%)

04:00 PM EDT on 06/02/23

Viking Therapeutics (NASDAQ:VKTX)

CAPS Rating: 3 out of 5

Current Price $22.28 Mkt Cap $2.2B
Open $22.19 P/E Ratio -23.76
Prev. Close $22.28 Div. (Yield) $0.00 (0.0%)
Daily Range $21.80 - $22.55 Volume 1,674,828
52-Wk Range $2.02 - $25.72 Avg. Daily Vol. 4,861,386

Caps

How do you think NASDAQ:VKTX will perform against the market?

Add Stock to CAPS Watchlist

All Players

52 Outperform
7 Underperform
 

All-Star Players

16 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:VKTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

usubanas (97.53)
Submitted December 07, 2017

Can go up easily 10X if good results in NASH. Same MOA as MDGL.

Jordrok (< 20)
Submitted May 05, 2018

No revenues yet...

NASDAQ:VKTX Summary

Fools bullish on NASDAQ:VKTX are also bullish on:

Fools bearish on NASDAQ:VKTX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about VKTX.

Recs

0
Member Avatar Bigsef77 (51.27) Submitted: 9/18/2018 10:33:58 AM : Outperform Start Price: $5.26 NASDAQ:VKTX Score: +265.81

Why Viking Therapeutics Stock Is Soaring Today
Motley Fool
George Budwell, The Motley Fool
,Motley Fool•September 18, 2018
What happened
Viking Therapeutics (NASDAQ: VKTX), a clinical-stage biotech, saw its shares rise by as much as 180% in premarket trading today. The spark?

Viking's shares are soaring in response to a positive mid-stage result for its experimental nonalcoholic steatohepatitis (NASH) medicine VK2809. Most critically, the drug seems to compare favorably to Madrigal Pharmaceuticals' (NASDAQ: MDGL) MGL-3196 in terms of both safety and efficacy.

As a reminder, Madrigal's shares exploded higher earlier this year after reporting mid-stage results for MGL-3196. So, not surprisingly, Madrigal's shares sank by a staggering 14% in pre-market trading on the news that a major rival might have a more potent drug in development.

Recs

0
Member Avatar rthr0 (54.04) Submitted: 9/6/2018 6:29:16 PM : Outperform Start Price: $11.68 NASDAQ:VKTX Score: +41.01

new drugs and emerging NASH market

Recs

0
Member Avatar Under5 (59.76) Submitted: 2/3/2018 10:15:10 AM : Outperform Start Price: $1.12 NASDAQ:VKTX Score: +1,811.22

long!

Leaderboard

Find the members with the highest scoring picks in VKTX.

Score Leader

Under5

Under5 (59.76) Score: +1,785.33

The Score Leader is the player with the highest score across all their picks in VKTX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. Under5 59.76 7/27/2017 5/25/2022 Outperform 5Y $1.12 +1,883.93% +72.71% +1,811.22 3 Comments
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. skyrocket29 67.29 7/24/2017 Outperform 1Y $1.16 +1,815.52% +73.81% +1,741.70 0 Comment
Corona20 39.75 5/24/2022 Outperform 5Y $2.17 +923.96% +9.99% +913.97 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. GoldMiner20 < 20 4/26/2022 Outperform 5Y $2.32 +857.76% +1.96% +855.79 0 Comment
Playa14 < 20 5/18/2022 Outperform 5Y $2.38 +833.61% +6.13% +827.48 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. usubanas 97.53 12/7/2017 3/9/2023 Outperform 5Y $2.85 +679.65% +62.78% +616.87 4 Comments
Playa17 < 20 9/12/2022 Outperform 5Y $3.15 +605.40% +4.76% +600.63 0 Comment
icewater3 68.78 1/28/2022 Outperform 3M $3.45 +544.06% -1.04% +545.10 0 Comment
degaston 90.01 10/19/2022 Outperform 5Y $4.02 +452.74% +16.06% +436.68 0 Comment
shonny2 31.73 1/7/2022 Outperform 5Y $4.31 +415.55% -8.48% +424.03 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for VKTX.